BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9303415)

  • 21. New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits.
    Täuber MG; Hackbarth CJ; Scott KG; Rusnak MG; Sande MA
    Antimicrob Agents Chemother; 1985 Mar; 27(3):340-2. PubMed ID: 3838872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion of 3-quaternary ammonium cephem antibiotics into cerebrospinal fluid of patients with bacterial meningitis.
    Modai J
    J Chemother; 1996 Feb; 8 Suppl 2():83-90. PubMed ID: 8738850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics.
    Kaplan SL; Mason EO; Barson WJ; Tan TQ; Schutze GE; Bradley JS; Givner LB; Kim KS; Yogev R; Wald ER
    Pediatr Infect Dis J; 2001 Apr; 20(4):392-6. PubMed ID: 11332663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study.
    Ricard JD; Wolff M; Lacherade JC; Mourvillier B; Hidri N; Barnaud G; Chevrel G; Bouadma L; Dreyfuss D
    Clin Infect Dis; 2007 Jan; 44(2):250-5. PubMed ID: 17173226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro bactericide activity of different antibiotic combinations to Streptococcus pneumoniae resistant to penicillin and cefotaxime].
    Tubau F; Liñares J; Ardanuy C; Martínez-Lacasa J; Fernández A; Cabellos C; Fernández-Viladrich P; Martín R
    Enferm Infecc Microbiol Clin; 1996 Dec; 14(10):590-5. PubMed ID: 9053000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.
    Gavaldà J; Capdevila JA; Almirante B; Otero J; Ruiz I; Laguarda M; Allende H; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1997 Apr; 41(4):795-801. PubMed ID: 9087492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin therapeutic drug monitoring in cerebrospinal fluid.
    Aouinti I; Charfi R; Trabelsi S; Gaïes E; Salouage I; Jebabli N; El Jebari H; Lakhal M; Klouz A
    Therapie; 2014; 69(6):529-30. PubMed ID: 25320941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penicillin and ceftriaxone susceptibility of Streptococcus pneumoniae isolated from cerebrospinal fluid of children with meningitis hospitalized in a tertiary hospital in Israel.
    Waisbourd-Zinman O; Bilavsky E; Tirosh N; Samra Z; Amir J
    Isr Med Assoc J; 2010 Apr; 12(4):225-8. PubMed ID: 20803882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between vancomycin penetration into cerebrospinal fluid and protein concentration in cerebrospinal fluid/serum albumin ratio.
    Ishikawa M; Yamazaki S; Suzuki T; Uchida M; Iwadate Y; Ishii I
    J Infect Chemother; 2019 Feb; 25(2):124-128. PubMed ID: 30424949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain.
    Gerber CM; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
    Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):866-70. PubMed ID: 10691197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibiotic resistance analysis of
    Ge LL; Han ZY; Liu AH; Zhu L; Meng JH
    Zhonghua Er Ke Za Zhi; 2017 Feb; 55(2):109-114. PubMed ID: 28173648
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapy for children with invasive pneumococcal infections. American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 1997 Feb; 99(2):289-99. PubMed ID: 9024464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
    J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s.
    Bradley JS; Scheld WM
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S213-21. PubMed ID: 9126696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and antibiotic resistance profiles of cerebrospinal fluid pathogens in children with acute bacterial meningitis in Yunnan province, China, 2012-2015.
    Jiang H; Su M; Kui L; Huang H; Qiu L; Li L; Ma J; Du T; Fan M; Sun Q; Liu X
    PLoS One; 2017; 12(6):e0180161. PubMed ID: 28662145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment.
    Kanegaye JT; Soliemanzadeh P; Bradley JS
    Pediatrics; 2001 Nov; 108(5):1169-74. PubMed ID: 11694698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review.
    John CC
    Clin Infect Dis; 1994 Feb; 18(2):188-93. PubMed ID: 8161625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Appearance of resistance to beta-lactam antibiotics during therapy for Streptococcus pneumoniae meningitis.
    Muñoz M; Valderrabanos ES; Diaz E; Silva JJ; Soult JA; Infante P; Lopez JD; Garcia-Curiel A
    J Pediatr; 1995 Jul; 127(1):98-9. PubMed ID: 7608819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamic evaluation of meropenem and cefotaxime for pediatric meningitis: a report from the OPTAMA program.
    Ellis JM; Kuti JL; Nicolau DP
    Paediatr Drugs; 2006; 8(2):131-8. PubMed ID: 16608373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.